United Therapeutics has scored a regulatory green light to start clinical trials for its genetically modified pig kidneys to ...

United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug application (IND ...

Silver Spring’s United Therapeutics Corp. (NASDAQ ... off “represents a significant step forward in our relentless mission to expand the availability of transplantable organs,” Leigh ...

United Therapeutics Corporation (Nasdaq ... of a xenokidney represents a significant step forward in our relentless mission to expand the availability of transplantable organs,” said Leigh ...

Two US biotech companies say the Food and Drug Administration has cleared them to conduct clinical trials of their ...

NEW YORK (AP) — The following is a list of initial public offerings planned for the coming week. Sources include IPO ETF manager Renaissance Capital, and SEC filings.

Klaus joins Epitopea after serving as Chief Development Officer (CDO) at Nykode Therapeutics, where he oversaw clinical development, regulatory affairs, and project management across oncology, ...

Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately ...

A first-in-class, brain-penetrant sGC stimulator, zagociguat is hypothesized to rebalance dysregulated cellular pathways in MELAS. By restoring cellular functions that support mitochondria, zagociguat ...